ask="100.00"
ask_size="200"
average_daily_volume="556418"
bid="41.00"
bid_size="100"
book_value="11.38"
change="-1.12"
change_from_200_day_moving_average="4.74"
change_from_50_day_moving_average="2.05"
change_from_52_week_high="-12.89"
change_From_52_week_low="27.36"
change_in_percent="-1.49%"
close="73.88"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="76.19"
high_52_weeks="86.77"
last_trade_date="2/2/2017"
last_trade_price="73.88"
last_trade_size="24054"
last_trade_time="4:00pm"
low="73.54"
low_52_weeks="46.52"
market_capitalization="3.02B"
moving_average_200_day="69.14"
moving_average_50_day="71.83"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="74.45"
pe_ratio="N/A"
peg_ratio="-0.41"
percent_change_from_200_day_moving_average="+6.86%"
percent_change_from_50_day_moving_average="+2.85%"
percent_change_from_52_week_high="-14.86%"
percent_change_from_52_week_low="+58.81%"
previous_close="75.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.59"
price_per_sales="23940.82"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="12.30"
stock_exchange="NMS"
symbol="RARE"
volume="378735"
weeks_range_52="46.52 - 86.77"
